首页> 外文期刊>Journal of peptide science: An official publication of the European Peptide Society >Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrugresistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii
【24h】

Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrugresistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii

机译:CPF-C1对多药耐药细菌的抗菌活性和膜活性机制,这是一种四倍体青蛙非洲爪蟾皮肤分泌物产生的新型抗菌肽。

获取原文
获取原文并翻译 | 示例
           

摘要

Hospital-acquired infections caused by multidrug-resistant bacteria pose significant challenges for treatment, which necessitate the development of new antibiotics. Antimicrobial peptides are considered potential alternatives to conventional antibiotics. The skin of Anurans (frogs and toads) amphibians is an extraordinarily rich source of antimicrobial peptides. CPF-C1 is a typical cationic antimicrobial peptide that was originally isolated from the tetraploid frog Xenopus clivii. Our results showed that CPF-C1 has potent antimicrobial activity against both sensitive and multidrug-resistant bacteria. It disrupted the outer and inner membranes of bacterial cells. CPF-C1 induced both propidium iodide uptake into the bacterial cell and the leakage of calcein from large liposome vesicles, which suggests amode of action that involves membrane disturbance. Scanning electron microscopy and transmission electron microscopy verified the morphologic changes of CPF-C1-treated bacterial cells and large liposome vesicles. The membrane-dependent mode of action signifies that the CPF-C1 peptide functions freely and without regard to conventional resistant mechanisms. Additionally, it is difficult for bacteria to develop resistance against CPF-C1 under this action mode. Other studies indicated that CPF-C1 had low cytotoxicity against mammalian cell. In conclusion, considering the increase in multidrugresistant bacterial infections, CPF-C1 may offer a new strategy that can be considered a potential therapeutic agent for the treatment of diseases caused by multidrug-resistant bacteria.
机译:由耐多药细菌引起的医院获得性感染给治疗带来了巨大挑战,这需要开发新的抗生素。抗菌肽被认为是常规抗生素的潜在替代品。无脊椎动物(青蛙和蟾蜍)两栖动物的皮肤是抗菌肽的极为丰富的来源。 CPF-C1是典型的阳离子抗菌肽,最初是从四倍体青蛙非洲爪蟾中分离出来的。我们的结果表明,CPF-C1对敏感和耐多药细菌均具有有效的抗菌活性。它破坏了细菌细胞的外膜和内膜。 CPF-C1诱导碘化丙锭进入细菌细胞内,以及钙黄绿素从大型脂质体囊泡中泄漏,这提示了涉及膜干扰的作用方式。扫描电镜和透射电镜证实了CPF-C1处理的细菌细胞和大脂质体囊泡的形态变化。依赖膜的作用方式表明CPF-C1肽可自由发挥功能,而无需考虑常规耐药机制。另外,在这种作用模式下细菌难以发展对CPF-C1的抗性。其他研究表明,CPF-C1对哺乳动物细胞的细胞毒性较低。总之,考虑到耐多药细菌感染的增加,CPF-C1可能提供了一种新的策略,可以将其视为治疗由多药耐药细菌引起的疾病的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号